Aflac (AFL) to Release Quarterly Earnings on Wednesday

Aflac (NYSE:AFL) will likely be posting its Q1 2025 quarterly earnings results after the market closes on Wednesday, April 30th. Analysts expect Aflac to post earnings of $1.69 per share and revenue of $4.53 billion for the quarter.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Trading Down 1.1 %

NYSE:AFL opened at $107.96 on Monday. Aflac has a 12-month low of $80.59 and a 12-month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock’s 50 day simple moving average is $107.14 and its 200-day simple moving average is $107.07. The firm has a market cap of $58.93 billion, a P/E ratio of 11.25, a PEG ratio of 3.24 and a beta of 0.81.

Insider Activity

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Aflac stock. Brighton Jones LLC raised its holdings in Aflac Incorporated (NYSE:AFL) by 64.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,570 shares of the financial services provider’s stock after buying an additional 5,708 shares during the quarter. Brighton Jones LLC’s holdings in Aflac were worth $1,507,000 at the end of the most recent quarter. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have commented on AFL. UBS Group raised their target price on Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Barclays dropped their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Keefe, Bruyette & Woods decreased their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. Finally, Morgan Stanley lowered their price target on Aflac from $105.00 to $100.00 and set an “equal weight” rating on the stock in a report on Thursday, April 10th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Aflac has an average rating of “Hold” and a consensus target price of $103.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.